Literature DB >> 18206511

Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations.

Duncan Lejtenyi, Bruce Mazer.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18206511     DOI: 10.1016/j.jaci.2007.11.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  11 in total

1.  Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations.

Authors:  L M Patrias; A C Klaver; M P Coffey; D A Loeffler
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

3.  Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.

Authors:  Philip O Rabel; Christina B Planitzer; Maria R Farcet; Thomas R Kreil
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

Review 4.  Advances in basic and clinical immunology in 2008.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

5.  Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG).

Authors:  A P Knutsen; L E Leiva; C Caruthers; J Rodrigues; R U Sorensen
Journal:  Clin Exp Immunol       Date:  2015-07-29       Impact factor: 4.330

6.  Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study.

Authors:  Fernanda Aimée Nobre; Isabela Garrido da Silva Gonzalez; Raquel Maria Simão; Maria Isabel de Moraes Pinto; Beatriz Tavares Costa-Carvalho
Journal:  BMC Immunol       Date:  2014-06-21       Impact factor: 3.615

7.  Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin.

Authors:  Pamella F Abghari; Pavadee Poowuttikul; Elizabeth Secord
Journal:  Glob Pediatr Health       Date:  2017-02-21

Review 8.  Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.

Authors:  Lenka Hromadkova; Saak Victor Ovsepian
Journal:  J Immunol Res       Date:  2019-08-06       Impact factor: 4.818

9.  The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency.

Authors:  Ailsa Robbins; Mathilde Bahuaud; Maxime Hentzien; Quentin Maestraggi; Coralie Barbe; Delphine Giusti; Richard Le Naour; Frederic Batteux; Amélie Servettaz
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

10.  Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections.

Authors:  Mohsen Foroughipour; Farahzad Jabbari Azad; Reza Farid Hosseini; Abbas Shirdel; Amir Reza Khalighi; Hadis Yousefzadeh; Homa Sadri; Toktam Moghiman; Hossein Hekmatkhah
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.